✨
AI Summary
- Poseida Therapeutics discusses challenges in allogeneic (allo) CGT development.
- Four key challenges for off-the-shelf therapies in 2024.
- Potential for significant progress in allogeneic therapies this year.
Guests on This Episode
KY
Kristin Yarema
1 podcast appearance